edetic acid has been researched along with lutetium in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| McAfee, JG; O'Mara, RE; Subramanian, G | 1 |
| Birnbaum, ER; Darnall, DW; Smolka, GE | 1 |
| DAVISON, FC; FEAVEL, JB; GRACA, JG | 1 |
| Cherepanov, VN; Ermolina, EG; Kuznetsova, RT; Sundholm, D; Valiev, RR | 1 |
| Akyurek, S; Kucuk, NO; Ozkan, E; Soydal, C | 1 |
| Baum, RP; Klette, I; Kulkarni, HR; Mueller, D; Schottelius, M; Schuchardt, C; Singh, A; Wester, HJ; Wiessalla, S; Wirtz, M | 1 |
| Ahmadzadehfar, H; Essler, M; Gaertner, F; Schlenkhoff, CD; Schmidt, M | 1 |
| Bode, A; Bögemann, M; Rahbar, K; Roll, W; Weckesser, M | 1 |
| Kumar, R; Mittal, BR; Parihar, AS; Singh, SK; Vadi, SK | 1 |
| Baum, RP; Kulkarni, HR; Langbein, T; Lehmann, C; Mueller, D; Schuchardt, C; Singh, A; Zhang, J | 1 |
| Bal, C; Ballal, S; Damle, NA; Sahoo, RK; Seth, A; Tripathi, M; Yadav, MP | 1 |
| Alexoff, D; Choi, SR; Kung, HF; Li, L; Ploessl, K; Yao, X; Zha, Z; Zhao, R; Zhu, L | 1 |
1 review(s) available for edetic acid and lutetium
| Article | Year |
|---|---|
Theranostics of prostate cancer: from molecular imaging to precision molecular radiotherapy targeting the prostate specific membrane antigen.
Topics: Aged; Dipeptides; Edetic Acid; Forecasting; Gallium Isotopes; Gallium Radioisotopes; Heterocyclic Compounds, 1-Ring; Humans; Lutetium; Male; Middle Aged; Oligopeptides; Positron Emission Tomography Computed Tomography; Precision Medicine; Prognosis; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals; Retrospective Studies; Theranostic Nanomedicine | 2018 |
11 other study(ies) available for edetic acid and lutetium
| Article | Year |
|---|---|
Rare earth nuclides as potential agents for skeletal imaging.
Topics: Animals; Bone and Bones; Bone Marrow; Edetic Acid; Erbium; Injections, Intravenous; Liver; Lutetium; Methods; Muscles; Rabbits; Radionuclide Imaging; Samarium; Skeleton; Technology, Radiologic | 1969 |
Rare earth metal ions as substitutes for the calcium ion in Bacillus subtilis -amylase.
Topics: Amylases; Bacillus subtilis; Calcium; Circular Dichroism; Dialysis; Dysprosium; Edetic Acid; Enzyme Activation; Erbium; Ferricyanides; Lanthanum; Lutetium; Neodymium; Praseodymium; Protease Inhibitors; Samarium; Spectrophotometry; Spectrum Analysis; Sulfonic Acids; Terbium; Ultraviolet Rays; Ytterbium; Yttrium | 1971 |
Comparative toxicity of stable rare earth compounds. II. Effect of citrate and edetate complexing on acute toxicity in mice and guinea pigs.
Topics: Animals; Cerium; Chelating Agents; Chlorides; Citrates; Citric Acid; Dysprosium; Edetic Acid; Erbium; Ethylenediamines; Europium; Gadolinium; Guinea Pigs; Holmium; Lanthanum; Lutetium; Metals, Rare Earth; Mice; Neodymium; Praseodymium; Samarium; Terbium; Thulium; Yttrium | 1962 |
Computational and experimental studies of the electronic excitation spectra of EDTA and DTPA substituted tetraphenylporphyrins and their Lu complexes.
Topics: Edetic Acid; Electrons; Lutetium; Models, Chemical; Models, Molecular; Pentetic Acid; Porphyrins; Quantum Theory; Spectrum Analysis | 2013 |
Marked Response to 177Lu Prostate-Specific Membrane Antigen Treatment in Patient With Metastatic Prostate Cancer.
Topics: Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Humans; Lutetium; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Oligopeptides; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed | 2016 |
177Lu-Labeled Prostate-Specific Membrane Antigen Radioligand Therapy of Metastatic Castration-Resistant Prostate Cancer: Safety and Efficacy.
Topics: Aged; Antigens, Surface; Cohort Studies; Dipeptides; Disease-Free Survival; Edetic Acid; Erythrocyte Count; Gallium Isotopes; Gallium Radioisotopes; Glutamate Carboxypeptidase II; Heterocyclic Compounds, 1-Ring; Humans; Leukocyte Count; Lutetium; Male; Neoplasm Metastasis; Oligopeptides; Organometallic Compounds; Pain; Patient Selection; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Radiometry; Radiopharmaceuticals; Treatment Outcome | 2016 |
Positive Influence of 177Lu PSMA-617 Therapy on Bone Marrow Depression Caused by Metastatic Prostate Cancer.
Topics: Aged; Anemia; Antineoplastic Agents; Bone Marrow Diseases; Bone Neoplasms; Compassionate Use Trials; Dipeptides; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Heterocyclic Compounds, 1-Ring; Humans; Lutetium; Male; Oligopeptides; Positron Emission Tomography Computed Tomography; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Radium; Technetium Tc 99m Medronate | 2016 |
Excellent Response to 177Lu-PSMA-617 Radioligand Therapy in a Patient With Advanced Metastatic Castration Resistant Prostate Cancer Evaluated by 68Ga-PSMA PET/CT.
Topics: Aged; Bone Neoplasms; Dipeptides; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Heterocyclic Compounds, 1-Ring; Humans; Lutetium; Male; Oligopeptides; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Radiopharmaceuticals | 2017 |
Unusual Case of Diffuse Penile Metastasis of Prostate Cancer on 68Ga PSMA PET/CT Imaging and 177Lu PSMA Posttherapy Scintigraphy.
Topics: Aged, 80 and over; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Humans; Lutetium; Male; Oligopeptides; Penile Neoplasms; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radioisotopes | 2018 |
Efficacy and Safety of 177Lu-PSMA-617 Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer Patients.
Topics: Adult; Aged; Aged, 80 and over; Dipeptides; Edetic Acid; Heterocyclic Compounds, 1-Ring; Humans; Ligands; Lutetium; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Treatment Outcome | 2020 |
New PSMA-Targeting Ligands: Transformation from Diagnosis (Ga-68) to Radionuclide Therapy (Lu-177).
Topics: Albumins; Animals; Antigens, Surface; Cell Line, Tumor; Chelating Agents; Edetic Acid; Gallium Radioisotopes; Glutamate Carboxypeptidase II; Humans; Ligands; Lutetium; Male; Mice; Prostatic Neoplasms; Radioisotopes; Tissue Distribution | 2022 |